Clinical trial
Stereotactic Radiotherapy for Renal Cancers: Phase I Study
NCT02811250 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Radiotherapy for Renal Cancers: Phase I Study
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- October 25, 2021
- Enrollment
- 13 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
renal cancer